ZEISS and Kyoto University consolidate strategic partnership
October 30, 2019
New ZEISS iCeMS Innovation Core collaborative laboratory opened Jena, Germany, Kyoto, Japan | ZEISS and Kyoto University are intensifying their cooperation and have signed a new strategic research agreement. As part of the agreement, the partners are opening the ZEISS iCeMS Innovation Core – a collaborative laboratory at Kyoto University’s Institute for Integrated Cell-Material Sciences [...]
Enrichment of human carcinoma cells for sensitive molecular analysis
October 30, 2019
FFPE Tissue Dissociation Kit from Miltenyi Biotec BERGISCH GLADBACH - The FFPE Tissue Dissociation Kit by Miltenyi Biotec enables the effective dissociation of formalin-fixed paraffin-embedded (FFPE) carcinoma samples for the specific enrichment and subsequent molecular analysis of carcinoma tumor cells. This enhances the sensitivity in molecular experiments, such as mutation analysis by next-generation sequencing (NGS). [...]
Evonetix expands facilities and relocates to central Cambridge, UK
October 30, 2019
15,000 sq. ft of laboratory and office space at Coldham’s Business Park will enable continued growth and development of the Company’s integrated desktop platform for DNA synthesis CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scalable, high-fidelity and rapid gene synthesis, today announced it has moved to Coldham’s Business Park, [...]
Twist Bioscience to Provide Target Enrichment Products for MGI in Europe and Asia Pacific
October 30, 2019
-- Companies Combine Best-in-Class Product Lines for Next-Generation Sequencing -- SOUTH SAN FRANCISCO, Calif.--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and MGI International Sales Co., Limited (MGI), a subsidiary of global genomics leader BGI Group, today announced a co-marketing agreement [...]
MGI and Jiajian Medicine reached strategic cooperation in genetic diseases
October 30, 2019
Recently, Shenzhen MGI Technology Co., Ltd. and Guangzhou Jiajian Medical Testing Co., Ltd. reached a strategic cooperation agreement in the clinical application direction of single gene genetic disease detection. Jiajian Medical will develop a whole-process overall solution for genetic testing of single-gene genetic diseases based on MGI's high-throughput sequencing platform to realize the localization, automation [...]
Akadeum and Agilent Team Up to Explore New Testing Workflow
October 30, 2019
Novel Akadeum microbubble technology can be the answer to improved quality and reduced costs across multiple fields of testing. Akadeum Life Sciences, Inc., an Ann Arbor-based biotechnology company, announced today that it has entered into a collaboration with Agilent Technologies, Inc. to work toward a new method of isolating target molecules for detection. Akadeum aims to disrupt [...]
LexaGene Closes C$6.64 Million Financing
October 30, 2019
LexaGene Announces Closing of CAD$6.64 Million Financing BEVERLY, Mass – (October 29, 2019) – LexaGene Holdings Inc. (TSX VENTURE: LXG) (OTCQB: LXXGF) (“LexaGene” or the “Company“) is pleased to announce that it has closed its previously announced offering of units (the “Units”) for aggregate gross proceeds of CAD$6.64 million (the “Offering”). The Company issued 12,769,626 Units at a price [...]
October 30, 2019
This project has been awarded to Esco and will be utilizing the Weighing and Dispensing Containment Isolator (WDCI), to be installed in Belgium. As with the majority of our units, the WDCI is highly adaptable to meet all the requirements specified by our client. The client's process involves the handling of potent powders requiring a [...]
ArcticZymes launch Glycerol-free and Triton FREE version of HL-dsDNase
October 30, 2019
ArcticZymes AS is pleased to announce the launch of HL-dsDNase Glycerol-free Triton FREE. This launch is a continuing step towards maintaining a completely EU REACH compliant product portfolio after Triton X-100 becomes subject to authorisation in January 2021. The convenient glycerol-free formulation is suitable for lyophilization and automated processes. The new formulation offers the same advantages [...]
Phenomenex Announces Direct Sales and Support in Poland
October 30, 2019
Torrance, Calif. – Phenomenex, Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, announced today that it will begin to directly serve customers in Poland, effective October 30, 2019. Direct presence in Poland will allow Phenomenex to provide customers with a variety of services such as access to [...]
